• 1. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 2. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 3. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739

Recent Advances in the Application of 4-IODO-1H-IMIDAZOLE-2-CARBALDEHYDE (CAS: 82322-25-6) in Chemical Biology and Pharmaceutical Research

The compound 4-IODO-1H-IMIDAZOLE-2-CARBALDEHYDE (CAS: 82322-25-6) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile reactivity and potential applications in drug discovery and development. This research briefing aims to summarize the latest findings related to this compound, focusing on its synthesis, biological activity, and emerging applications in medicinal chemistry.

Recent studies have highlighted the unique structural features of 4-IODO-1H-IMIDAZOLE-2-CARBALDEHYDE, which make it a valuable intermediate in the synthesis of heterocyclic compounds. Its iodine substituent and aldehyde functional group provide multiple sites for further chemical modifications, enabling the development of novel bioactive molecules. Researchers have successfully utilized this compound in the synthesis of imidazole-based inhibitors targeting key enzymes involved in inflammatory and oncogenic pathways.

In a groundbreaking study published in the Journal of Medicinal Chemistry, 4-IODO-1H-IMIDAZOLE-2-CARBALDEHYDE was employed as a key building block for the development of selective kinase inhibitors. The study demonstrated that derivatives of this compound exhibited potent inhibitory activity against specific tyrosine kinases, with IC50 values in the nanomolar range. These findings suggest promising therapeutic potential for treating cancers characterized by dysregulated kinase signaling.

Another significant application of 4-IODO-1H-IMIDAZOLE-2-CARBALDEHYDE has been in the field of antimicrobial research. Recent investigations have shown that imidazole derivatives synthesized from this compound display broad-spectrum activity against drug-resistant bacterial strains. The mechanism of action appears to involve disruption of bacterial cell membrane integrity, making these compounds particularly valuable in the fight against antibiotic resistance.

From a synthetic chemistry perspective, novel methodologies have been developed for the efficient preparation of 4-IODO-1H-IMIDAZOLE-2-CARBALDEHYDE and its derivatives. A recent publication in Organic Letters described an improved catalytic system for the iodination of imidazole precursors, significantly enhancing the yield and purity of the target compound. These advancements in synthetic protocols are expected to facilitate broader exploration of this chemical scaffold in drug discovery programs.

Looking forward, the unique properties of 4-IODO-1H-IMIDAZOLE-2-CARBALDEHYDE position it as a promising candidate for the development of novel therapeutic agents and chemical probes. Ongoing research is exploring its potential in targeted protein degradation strategies and as a versatile handle for bioconjugation in antibody-drug conjugates. The compound's ability to serve as a molecular scaffold for diverse pharmacophores continues to attract interest from both academic and industrial researchers in the pharmaceutical sector.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)